(Press-News.org) LOS ANGELES (Sept. 25, 2012) – Chronic, debilitating pain and potential organ failure are what approximately 100,000 sickle cell patients in the United States live with each day. Yutaka Niihara, M.D., M.P.H. - lead investigator at The Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center (LA BioMed) and co-founder of Emmaus Medical, Inc., an LA BioMed spin-off company - is developing a low-cost, noninvasive treatment that helps provide relief for patients suffering from the debilitating effects of sickle cell disease.
Dr. Niihara and his team of investigators discovered that L-glutamine – which is the most common free-form amino acid in the body – can help alleviate many of the painful symptoms associated with sickle cell when used in powder form and added to liquid.
Sickle cell is an inherited disease that causes red blood cells to become oxidized, sticky, and crescent or sickle-shaped instead of smooth, pliable, and round. It can lead to anemia, organ damage, chronic and acute pain, and a host of other problems. L-glutamine, in its powder form, helps to reduce the oxidation of red blood cells.
Dr. Niihara first began seeking alternative treatments for sickle cell nearly 20 years ago, after years of seeing patients suffer from this debilitating disease. He was encouraged by Dr. Charles Zerez, an LA BioMed investigator in the 1980s and 1990s, to pursue glutamine research. Of the approximately 80 medications for sickle cell that have entered into clinical trials, this therapy is one of only three experimental treatments to reach Phase III trials, which are usually the last trials conducted before the Food and Drug Administration approves a treatment to be made widely available to the patient population.
"As a physician, I have seen firsthand the severe pain suffered by patients with sickle cell disease," said Dr. Niihara. "We are pleased to have reached this stage in our development of this potential treatment, and hope to bring relief to the millions of people suffering from this disorder."
According to the Centers for Disease Control (CDC), there are approximately 100,000 people in the United States living with sickle cell disease, and approximately 3 million people carrying the sickle cell trait. With Dr. Niihara's treatment in Phase III clinical trials, this should come as a welcome relief to millions of people worldwide, as other treatment options such as pain medication, hydration, or bone marrow transplants are either not well tolerated, are too costly, or have limited availability.
"We are excited about the potential development of a novel treatment for the millions of people who suffer from the effects of sickle cell disease," said David I. Meyer, Ph.D., president and CEO of LA BioMed. "The achievements of Dr. Niihara and his team of researchers demonstrate the pioneering spirit that has kept LA BioMed at the forefront of medical discoveries that have helped transform the lives of so many."
Dr. Niihara's L-glutamine treatment recently received an Orphan Medicinal Product designation from the European Commission (EC). This designation follows a recommendation announced in May from the European Medicines Agency's (EMA) Committee for Orphan Medicinal Products. The therapy currently has orphan drug designation and "fast track" status in the United States, which is a process designed to facilitate the development and expedite the review of drugs to treat serious diseases and fill an unmet medical need.
###Emmaus Medical is a private pharmaceutical company dedicated to developing and bringing to market new treatments for rare diseases and conditions. In addition to the development of the sickle cell therapy, Emmaus was also recently awarded a five-year contract from the Department of Veterans Affairs to supply the VA with its prescription drug NutreStore to treat short bowel syndrome, which prevents patients from properly absorbing nutrients.
About LA BioMed
Founded in 1952, LA BioMed is one of the country's leading nonprofit independent biomedical research institutes. It has approximately 100 principal researchers conducting studies into improved treatments and cures for cancer, inherited diseases, infectious diseases, illnesses caused by environmental factors and more. It also educates young scientists and provides community services, including prenatal counseling and childhood nutrition programs. LA BioMed is academically affiliated with the David Geffen School of Medicine at UCLA and located on the campus of Harbor-UCLA Medical Center. For more information, please visit www.LABioMed.org.
Dr. Yutaka Niihara: Novel therapy helps ease pain and suffering for sickle cell patients
2012-09-25
ELSE PRESS RELEASES FROM THIS DATE:
Researchers develop new technique for IDing proteins secreted by cells
2012-09-25
Researchers from North Carolina State University have developed a new technique to identify the proteins secreted by a cell. The new approach should help researchers collect precise data on cell biology, which is critical in fields ranging from zoology to cancer research.
The work is important because cells communicate by secreting proteins. Some of the proteins act on the cell itself, telling it to grow or multiply, for example. But the proteins can also interact with other cells, influencing them to perform any biological function.
Traditionally, scientists who wanted ...
Oscillating microscopic beads could be key to biolab on a chip
2012-09-25
CAMBRIDGE, Mass. -- If you throw a ball underwater, you'll find that the smaller it is, the faster it moves: A larger cross-section greatly increases the water's resistance. Now, a team of MIT researchers has figured out a way to use this basic principle, on a microscopic scale, to carry out biomedical tests that could eventually lead to fast, compact and versatile medical-testing devices.
The results, based on work by graduate student Elizabeth Rapoport and assistant professor Geoffrey Beach, of MIT's Department of Materials Science and Engineering (DMSE), are described ...
'The Dust Queen's' research stars in new American Chemical Society video
2012-09-25
WASHINGTON, Sept. 25, 2012 — A new episode in the American Chemical Society's (ACS') popular Prized Science video series features insights into the effects of wind-blown dust on human health and climate from Vicki Grassian, Ph.D. She has jokingly been called "the Dust Queen" and is a noted authority on the tiny particles of sand and dirt, termed mineral dust, that are transported from areas as remote as the Sahara Desert.
The video, produced by the ACS, the world's largest scientific society, is available at www.acs.org/PrizedScience and by request on DVD. Prized Science ...
By improving pain treatment, therapy in dogs, research offers medical insight for humans
2012-09-25
MANHATTAN, KAN. -- A Kansas State University professor's research improving post-surgery pain treatment and osteoarthritis therapy in dogs may help develop better ways to treat humans for various medical conditions.
From the use of hot and cold packs to new forms of narcotics, James Roush, professor of clinical sciences, is studying ways to lessen pain after surgery and improve care for small animals, particularly dogs. He is working with the clinical patients who come to the College of Veterinary Medicine's Veterinary Health Center.
Because humans and dogs experience ...
Grief stages can be likened to pinball machine workings, Baylor University Researcher says
2012-09-25
WACO, Texas (Sept. 25, 2012) — Moving through the traditional stages of grief can be as unpredictable as playing a pinball machine, with triggers of sorrow acting like pinball rudders to send a mourner into a rebound rather than an exit, according to a case study by a Baylor University researcher and a San Antonio psychologist.
For some, grieving is complete after the loss is accepted. But for others, such events as the anniversary of a death or a scene that jogs the memory can send them slamming into grief again, according to a case study by Margaret Baier, Ph.D., an ...
Spirituality key to Chinese medicine success
2012-09-25
Are the longevity and vitality of traditional Chinese medicine (TCM) due to its holistic approach? Indeed, Chinese medicine is not simply about treating illness, but rather about taking care of the whole person—body, mind, and spirit. According to an analysis¹ of TCM's origins and development by Lin Shi from Beijing Normal University and Chenguang Zhang from Southwest Minzu University in China, traditional Chinese medicine is profoundly influenced by Chinese philosophy and religion. To date, modern science has been unable to explain the mechanisms behind TCM's effects. ...
Minority children at a higher risk for weight problems in both the US and England
2012-09-25
Los Angeles (September 25, 2012)- With ties to diabetes, hypertension, and high cholesterol, childhood obesity in wealthy countries is certainly of growing concern to researchers. A new study explores the ties between childhood weight problems, socioeconomic status, and nationality and finds that race, ethnicity, and immigrant status are risk factors for weight problems among children in the US and England. This new study was published in the September issue of The ANNALS of the American Academy of Political and Social Science (a SAGE journal) titled "Migrant Youths and ...
'Green IT' to be presented in Baltimore
2012-09-25
How can laptop users be kinder to the environment by using less power?
University of Cincinnati computer science doctoral student Dippy Aggarwal will be among the leaders in their fields who are sharing emerging research and career interests at the Grace Hopper Celebration of Women in Computing Conference, Oct. 3-6, in Baltimore. She'll present early results of her research in a poster presentation, "Leveraging Power Analytics and Linked Data for Enterprise Computing," on Wednesday, Oct. 3.
Aggarwal's presentation evolved from a summer 2011 internship at the Digital ...
Human brains develop wiring slowly, differing from chimpanzees, GW University professor finds
2012-09-25
WASHINGTON—Research comparing brain development in humans and our closest nonhuman primate relatives, chimpanzees, reveals how quickly myelin in the cerebral cortex grows, shedding light on the evolution of human cognitive development and the vulnerability of humans to psychiatric disorders, a GW professor finds. Myelin is the fatty insulation surrounding axon connections of the brain.
Recent research by Chet Sherwood, associate professor of anthropology in Columbian College of Arts and Sciences, along with Daniel Miller, a former GW graduate student, and other colleagues, ...
Nothing fishy about fish oil fortified nutrition bars
2012-09-25
CHICAGO—In today's fast-paced society, consumers often reach for nutrition bars when looking for a healthy on-the-go snack. A new study in the September issue of the Journal of Food Science published by the Institute of Food Technologists (IFT) found that partially replacing canola oil with fish oil in nutrition bars can provide the health benefits of omega-3 fatty acids without affecting the taste.
Producers have been hesitant to incorporate fish oil into foods because it tends to give off a fishy taste or smell, therefore requiring additional processing steps to eliminate ...